Search for other papers by Patrick W. Owens in
Google Scholar
PubMed
Cancer Genetics Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom
Search for other papers by Terri P. McVeigh in
Google Scholar
PubMed
Search for other papers by Eoin J. Fahey in
Google Scholar
PubMed
Search for other papers by Marcia Bell in
Google Scholar
PubMed
Search for other papers by Denis S. Quill in
Google Scholar
PubMed
Search for other papers by Michael J. Kerin in
Google Scholar
PubMed
Search for other papers by Aoife J. Lowery in
Google Scholar
PubMed
lobectomy alone as an option for those with tumours 1–4 cm without risk factors. Emerging evidence also advocates active surveillance for microPTC, with interval growth over 5 years observed in < 15% of patients [ 18 , 19 ]. Improved identification and
Search for other papers by Amanda La Greca in
Google Scholar
PubMed
Search for other papers by Bin Xu in
Google Scholar
PubMed
Search for other papers by Ronald Ghossein in
Google Scholar
PubMed
Search for other papers by R. Michael Tuttle in
Google Scholar
PubMed
Search for other papers by Mona M. Sabra in
Google Scholar
PubMed
metastasis on follow-up. At the discretion of the treating physician, 25 patients were initially treated with active surveillance without RAI ablation after the initial surgery. Only 3 of these patients had N1 disease, with up to 3 affected nodes measuring
Search for other papers by Ilaria Muller in
Google Scholar
PubMed
Search for other papers by Carla Moran in
Google Scholar
PubMed
Search for other papers by Beatriz Lecumberri in
Google Scholar
PubMed
Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Search for other papers by Neil Robertson in
Google Scholar
PubMed
Search for other papers by Joanne Jones in
Google Scholar
PubMed
Search for other papers by Colin M. Dayan in
Google Scholar
PubMed
autoantibodies in euthyroid patients during surveillance (1,∅○○○). 8. Should Patients Be Routinely Screened with Thyroid Imaging post IRT? In the phase III clinical trials comparing alemtuzumab with interferon β-1a in highly active MS, no overall
Search for other papers by F. Cecoli in
Google Scholar
PubMed
Search for other papers by E.M. Ceresola in
Google Scholar
PubMed
Search for other papers by V. Altrinetti in
Google Scholar
PubMed
Search for other papers by M. Cabria in
Google Scholar
PubMed
Search for other papers by M. Cappagli in
Google Scholar
PubMed
Search for other papers by A. Montepagani in
Google Scholar
PubMed
Search for other papers by C.M. Cuttica in
Google Scholar
PubMed
Search for other papers by U. Filippi in
Google Scholar
PubMed
Search for other papers by D. Saverino in
Google Scholar
PubMed
Search for other papers by M. Raffa in
Google Scholar
PubMed
Search for other papers by M. Caputo in
Google Scholar
PubMed
Search for other papers by F. Minuto in
Google Scholar
PubMed
Search for other papers by M. Giusti in
Google Scholar
PubMed
Search for other papers by M. Bagnasco in
Google Scholar
PubMed
from observation to total thyroidectomy [ 10 ]. MPTC mortality rate is very low, ranging from 0.2 to 2.2%. The 2015 American Thyroid Association Thyroid Cancer Management Guidelines [ 11 ] state that active surveillance ‘can be considered' as an
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
Endocrinology Division, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA
Search for other papers by Henry B Burch in
Google Scholar
PubMed
Search for other papers by Petros Perros in
Google Scholar
PubMed
Search for other papers by Tomasz Bednarczuk in
Google Scholar
PubMed
Search for other papers by David S Cooper in
Google Scholar
PubMed
Search for other papers by Peter J Dolman in
Google Scholar
PubMed
Search for other papers by Angela M Leung in
Google Scholar
PubMed
Search for other papers by Ilse Mombaerts in
Google Scholar
PubMed
Search for other papers by Mario Salvi in
Google Scholar
PubMed
Search for other papers by Marius N Stan in
Google Scholar
PubMed
selenium selenite 100 μg twice daily for 6 months may be considered for patients with mild, active TED, particularly in regions of selenium insufficiency. Key Point 6.2.1: The clinician should regularly assess the psychosocial impact of concerns
Search for other papers by Chantal A Lebbink in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Renuka P Dias in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Louise Izatt in
Google Scholar
PubMed
Search for other papers by Heiko Krude in
Google Scholar
PubMed
Search for other papers by Kerstin Lorenz in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Arnoldo Piccardo in
Google Scholar
PubMed
Search for other papers by Manuel Sobrinho-Simões in
Google Scholar
PubMed
Search for other papers by Toru Takano in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by Frederik A Verburg in
Google Scholar
PubMed
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
total thyroidectomy vs active surveillance ( 91 ). Similar to the 2015 ATA Pediatric Guideline, the expert panel recommends extensive neck US in these cases to detect contralateral disease/regional lymph node spread ( 8 ). Patients with no disease in US
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Barbara Demeneix in
Google Scholar
PubMed
Search for other papers by Ashok Bhaseen in
Google Scholar
PubMed
Search for other papers by Thomas H. Brix in
Google Scholar
PubMed
(however, according to patient associations, the ANSM documents requesting the formulation change have yet to be released). In January 2018, 17,310 reports of adverse effects had been received by the national site for drug surveillance (BNPV, Base National
Search for other papers by Matthieu Bosset in
Google Scholar
PubMed
Search for other papers by Maxime Bonjour in
Google Scholar
PubMed
Search for other papers by Solène Castellnou in
Google Scholar
PubMed
Search for other papers by Zakia Hafdi-Nejjari in
Google Scholar
PubMed
Search for other papers by Claire Bournaud-Salinas in
Google Scholar
PubMed
Search for other papers by Myriam Decaussin-Petrucci in
Google Scholar
PubMed
Laboratoire Health Services and Performance Research (EA 7425 HESPER), Université Claude Bernard Lyon 1, Villeurbanne, France
Search for other papers by Jean Christophe Lifante in
Google Scholar
PubMed
Search for other papers by Agnès Perrin in
Google Scholar
PubMed
Search for other papers by Jean-Louis Peix in
Google Scholar
PubMed
CarMeN Laboratory, Université Claude-Bernard Lyon 1, Inserm U1060, INRA U1397, INSA Lyon, IMBL, Villeurbanne, France
Search for other papers by Philippe Moulin in
Google Scholar
PubMed
Search for other papers by Geneviève Sassolas in
Google Scholar
PubMed
Search for other papers by Michel Pugeat in
Google Scholar
PubMed
Registre des Cancers Thyroïdiens du Département du Rhône, Hospices Civils de Lyon, Groupement Hospitalier Est, Bron, France
Laboratoire Health Services and Performance Research (EA 7425 HESPER), Université Claude Bernard Lyon 1, Villeurbanne, France
Search for other papers by Françoise Borson-Chazot in
Google Scholar
PubMed
benefit from active surveillance instead of surgery [ 4 , 26 , 27 ]. Their incidence is increasing as they are often found fortuitously, leading to an overdiagnosis of thyroid cancers [ 4 , 28 - 30 ]. In line with the present results, contralateral
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Steen J. Bonnema in
Google Scholar
PubMed
Search for other papers by Murat Faik Erdogan in
Google Scholar
PubMed
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Rose Ngu in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
cytological result, FNA should be repeated within 3 months to reduce the rate of false-negative samples. In case of subcentimeter nodules with high-risk US features, active surveillance is recommended, provided that there are no abnormal lymph nodes and the
Search for other papers by Rui Guo in
Google Scholar
PubMed
Search for other papers by Bowen Zheng in
Google Scholar
PubMed
Search for other papers by Tao Wu in
Google Scholar
PubMed
Search for other papers by Yufan Lian in
Google Scholar
PubMed
Search for other papers by Tinghui Yin in
Google Scholar
PubMed
Search for other papers by Yuting He in
Google Scholar
PubMed
Search for other papers by Jingya Qin in
Google Scholar
PubMed
Search for other papers by Zhicheng Yao in
Google Scholar
PubMed
Search for other papers by Wen Xu in
Google Scholar
PubMed
Search for other papers by Jie Ren in
Google Scholar
PubMed
using the VRS01 RFA system (STARmed, Korea) and initiated internal cooling of the 18G electrodes with 10 mm or 7 mm active tips under the guidance of the same US equipment. Local anesthesia, a lateral approach, a moving-shot technique, and a